TGFβ Signaling Sensitizes MEKi-Resistant Human Melanoma to Targeted Therapy-Induced Apoptosis

Researchers demonstrated that parallel activation of TGFβ signaling and MAPK pathway inhibition caused a complete switch of TGFβ target genes from promoting pro-invasive processes to fueling pro-apoptotic pathways.